John Mitchell
Critical Care Medicine · Charleston, SCNPI 1205886124
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 482 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,109, 5.8 times the $364 reported in 2019.
Across 482 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Jazz Pharmaceuticals Inc.$1K
- GSK$992
- Insmed, Inc.$723
- Axsome Therapeutics, Inc.$527
- Sanofi$443
- plus $4K from 35 others
Across 10 payments — averaging $11,693 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$94K
- Boehringer Ingelheim$23K
What the payments were for
- Food & beverage$9,33698%
- Education$2332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 85 | $1,555 |
| Jazz Pharmaceuticals Inc. | 54 | $1,074 |
| GSK | 57 | $992 |
| Insmed, Inc. | 32 | $723 |
| Axsome Therapeutics, Inc. | 23 | $527 |
| Sanofi | 19 | $443 |
| Regeneron Healthcare Solutions, Inc. | 16 | $403 |
| Actelion Pharmaceuticals US, Inc. | 26 | $396 |
| Boehringer Ingelheim | 21 | $391 |
| Harmony Biosciences LLC | 19 | $343 |
| Mylan Specialty L.p. | 19 | $318 |
| Amgen | 14 | $306 |
| Mallinckrodt Hospital Products Inc. | 9 | $264 |
| United Therapeutics Corporation | 8 | $216 |
| Philips North America LLC | 11 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $149 |
| Merck | 7 | $146 |
| Verona Pharma, Inc. | 5 | $118 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $104 |
| Inspire Medical Systems, Inc. | 3 | $98 |
| Baxter Healthcare | 4 | $84 |
| Inari Medical, Inc. | 2 | $84 |
| Novartis | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Lilly USA, LLC | 3 | $59 |
| Inogen, Inc. | 6 | $58 |
| AbbVie | 3 | $58 |
| Genentech USA, Inc. | 2 | $45 |
| Resmed Corp | 2 | $43 |
| Viatris Specialty LLC | 2 | $38 |
| Shionogi Inc | 1 | $31 |
| Eisai Inc. | 2 | $29 |
| Electromed, Inc. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Medtronic | 1 | $19 |
| CSL Behring | 1 | $18 |
| Gilead | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $14 |
| Optinose US, Inc. | 1 | $13 |
| Advanced Respiratory, Inc | 1 | $12 |
How this compares
$9,568 in reported general payments places this provider in the 80th percentile of 93 critical care medicine providers in South Carolina.
See all critical care medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 26 | $423,240 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 150 | $138,058 |
| Fasenra PenBenralizumab | 13 | $72,494 |
| XolairOmalizumab | 15 | $46,906 |
| Breo ElliptaFluticasone/Vilanterol | 75 | $37,380 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 48 | $28,751 |
| EliquisApixaban | 26 | $22,487 |
| XareltoRivaroxaban | 15 | $21,376 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 24 | $19,698 |
| SunosiSolriamfetol Hcl | 17 | $18,892 |
| SymbicortBudesonide/Formoterol Fumarate | 65 | $16,443 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $12,329 |
| Wixela InhubFluticasone Propion/Salmeterol | 61 | $11,121 |
| DuleraMometasone/Formoterol | 15 | $8,573 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 44 | $8,488 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $992 | $204,189273 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $1,555 | $28,77281 claims |
| Boehringer IngelheimStiolto Respimat | $391 | $19,69824 claims |
| Axsome Therapeutics, Inc.Sunosi | $527 | $18,89217 claims |
| MerckDulera | $146 | $8,57315 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $66 | $2,42511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 93 critical care medicine providers in South Carolina.
Other critical care medicine in Charleston
- Charlton StrangeCharleston$205K
- Rahul ArgulaCharleston$186K
- James CarswellCharleston$159K
- Nicholas FoxCharleston$88K
- Christopher GilbertCharleston$44K
- Gregory SquiresCharleston$14K
- Luca PaolettiCharleston$5K
- Jennings NestorCharleston$5K
- Tatsiana BeikoCharleston$4K
- Stephen SexauerCharleston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.